Smith+Nephew Unveils New Rotator Cuff Repair System at AAOS 2026

Event summary

  • Smith+Nephew will showcase its rotator cuff repair portfolio, including the new Tendon Seam™ Repair System and REGENETEN Bioinductive Implant, at the AAOS 2026 Annual Meeting in New Orleans from March 2-6, 2026.
  • The Tendon Seam™ Repair System received 510(k) clearance in 2023 and is designed to reduce re-tear rates and improve patient outcomes.
  • The REGENETEN Bioinductive Implant has been used in over 250,000 procedures globally since its introduction in 2014.
  • AAOS's revised Clinical Practice Guideline now supports the use of bioinductive implants for rotator cuff repair, highlighting their value in reducing re-tear rates and improving patient outcomes.

The big picture

Smith+Nephew's introduction of the Tendon Seam™ Repair System and the continued success of the REGENETEN Bioinductive Implant come at a time when the rotator cuff repair market is growing, with approximately 500,000 procedures performed annually in the US. The AAOS's revised Clinical Practice Guideline further validates the use of bioinductive implants, potentially driving increased market adoption and competition in this segment. Smith+Nephew's strategic focus on combining biomechanical repair and biological augmentation positions it to capture a significant share of this evolving market.

What we're watching

Market Adoption
How the Tendon Seam™ Repair System will be integrated into existing rotator cuff repair procedures and its potential to disrupt the market.
Regulatory Impact
Whether the AAOS's revised Clinical Practice Guideline will accelerate the adoption of bioinductive implants in rotator cuff repair.
Competitive Dynamics
The pace at which Smith+Nephew can differentiate itself from competitors in the rotator cuff repair market with its new portfolio.